Medclair AB (NGM:MCLR) ROCE % : -21.71% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medclair AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medclair AB's annualized ROCE % for the quarter that ended in Sep. 2024 was -21.71%.

Medclair AB ROCE % Historical Data

The historical data trend for Medclair AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medclair AB ROCE % Chart

Medclair AB Annual Data

Trend

Apr15

Apr16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-22.20

-8.79

-25.90

-8.78

-4.68

Medclair AB Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															6.03	-13.16	-1.68	-10.96	-21.71

Medclair AB ROCE % Calculation

Medclair AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-2.41	/	( ( (63.901 - 10.772)	+	(58.646 - 8.692) )	/ 2 )
	=	-2.41	/	( (53.129	+	49.954)	/ 2 )
	=	-2.41	/	51.5415
	=	-4.68 %

Medclair AB's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-11.304	/	( ( (67.517 - 14.015)	+	(60.01 - 9.355) )	/ 2 )
	=	-11.304	/	( ( 53.502	+	50.655 )	/ 2 )
	=	-11.304	/	52.0785
	=	-21.71 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Medclair AB (NGM:MCLR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medclair AB ROCE % Related Terms

Thank you for viewing the detailed overview of Medclair AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medclair AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medclair AB (NGM:MCLR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Box 3113, Stockholm, SWE, 103 62

Website

https://www.medclair.com

Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes up to 99% of the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.

Medclair AB Headlines

No Headlines